| Product NDC: | 51224-301 |
| Proprietary Name: | Alendronate Sodium |
| Non Proprietary Name: | Alendronate Sodium |
| Active Ingredient(s): | 70 mg/75mL & nbsp; Alendronate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51224-301 |
| Labeler Name: | TAGI Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090520 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130506 |
| Package NDC: | 51224-301-10 |
| Package Description: | 4 BOTTLE, UNIT-DOSE in 1 CARTON (51224-301-10) > 75 mL in 1 BOTTLE, UNIT-DOSE |
| NDC Code | 51224-301-10 |
| Proprietary Name | Alendronate Sodium |
| Package Description | 4 BOTTLE, UNIT-DOSE in 1 CARTON (51224-301-10) > 75 mL in 1 BOTTLE, UNIT-DOSE |
| Product NDC | 51224-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alendronate Sodium |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20130506 |
| Marketing Category Name | ANDA |
| Labeler Name | TAGI Pharma, Inc. |
| Substance Name | ALENDRONATE SODIUM |
| Strength Number | 70 |
| Strength Unit | mg/75mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |